Research coauthored by RTI Health Solutions researchers will be presented at the 2022 European Congress of Clinical Microbiology and Infectious Diseases.
Comparing the public health impact of a 15- or 20-valent pneumococcal conjugate vaccine paediatric national immunisation programme in Portugal. Perdizet J, da Silva Maia AS, Teixeira R, Sundaram V, Wasserman M, McDade C, Wilson M.
Infant pneumococcal conjugate vaccine programs result in substantial cost-savings and cases averted in the United Kingdom. Mikudina B, Vyse AJ, Czudek C, Ellsbury GF, Perdrizet J, Wasserman M, McDade C, Wilson M.
